EFFECTIVENESS OF HB2 (ANTI-CD7) - SAPORIN IMMUNOTOXIN IN AN IN-VIVO MODEL OF HUMAN T-CELL LEUKEMIA DEVELOPED IN SEVERE COMBINED IMMUNODEFICIENT MICE

The transplantation of the human T-cell acute lymphoblastic leukaemia (T-ALL) cell line HSB-2 into severe combined immunodeficient (SCID) mi ce was found to produce a disseminated pattern of leukaemia similar to that seen in man. The intravenous injection of 10(7) HSB-2 cells was associated with a universally fatal leukaemia. Histopathological exami nation of animals revealed the spread of leukaemia initially from bone marrow to involve all major organs including the meninges. An immunot oxin (HB2-Sap) was constructed by conjugating the anti-CD7 MAb HB2 to the ribosome-inactivating protein saporin. An in vitro protein synthes is inhibition assay revealed specific delivery of HB2-Sap immmunotoxin (IT) to CD7(+) HSB-2 target cells with an IC50 of 4.5 pM. When SCID m ice were injected with 10(6) HSB-2 cells and then treated 8 days later with a single intravenous dose of 10 mu g of immunotoxin there was a significant therapeutic effect evidenced by the numbers of animals sur viving in the therapy group compared with untreated controls (chi 2 = 5.348, P = 0.021). These results demonstrate the useful application of human leukaemia xenografts in SCID mice and the potential therapeutic effect of an anti-CD7 immunotoxin in human T-ALL.